% | $
Quotes you view appear here for quick access.

Sunesis Pharmaceuticals, Inc. Message Board

  • mining_phd mining_phd Oct 26, 2012 4:47 AM Flag

    SNSS versus CYCC


    CYCC and SNSS do not compete. CYCC is going after the much larger first line market opportunity. In contrast, SNSS is going after relapsed second line cases. In addition, SNSS are using a protocol of Voreloxin with toxic Chemo and is not being submitted as a single agent. Bottom line, SNSS can't shine CYCC's shoes.

    This topic is deleted.
4.04-0.07(-1.70%)3:59 PMEDT